Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bridgebio Pharma Inc (BBIO)

Bridgebio Pharma Inc (BBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bridgebio Pharma Inc 421 Kipling Street Palo Alto CA 94301 USA

P: 650-391-9740

Description:

BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.

Key Statistics

Overview:

Market Capitalization, $K 8,210,455
Shares Outstanding, K 148,956
Annual Sales, $ 8,250 K
Annual Net Income, $ -448,720 K
Last Quarter Sales, $ 120 K
Last Quarter Net Income, $ -119,980 K
60-Month Beta 0.87
% of Insider Shareholders 40.32%
% of Institutional Shareholders 81.26%
Float, K 88,897
% Float 59.68%

Growth:

1-Year Return 104.24%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/12/21
Earnings Per Share ttm -3.80
EPS Growth vs. Prev Qtr -3.06%
EPS Growth vs. Prev Year -62.90%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

BBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -163.66%
Return-on-Assets % -53.00%
Profit Margin % -5,439.03
Net Margin % N/A
Debt/Equity 4.48
Price/Sales 992.26
Price/Cash Flow N/A
Price/Book 63.46
Book Value/Share 0.87
Interest Coverage -12.79
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar